| Literature DB >> 29018044 |
Stefano Serra1, Runjan Chetty1.
Abstract
RNF43 (E3 ubiquitin-protein ligase RNF43 or RING-type E3 ubiquitin transferase RNF43) functions as a tumor suppressor, by exerting a predominant negative feedback mechanism in the Wnt/β-catenin signaling pathway. RNF43 inhibits Wnt/beta-catenin signaling by ubiquitinating Frizzled receptor and targeting it to the lysosomal pathway for degradation. Loss of function of RNF43 results in decrease/lack of degradation of Frizzled with enhancement of Wnt/β-catenin signaling pathway. Mutations of RNF43 have been reported in different cancers. We describe the structure of RNF43, its function and most frequent mutations in different cancers. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: cancer; colorectal cancer; gi neoplasms pancreatic
Mesh:
Substances:
Year: 2017 PMID: 29018044 DOI: 10.1136/jclinpath-2017-204763
Source DB: PubMed Journal: J Clin Pathol ISSN: 0021-9746 Impact factor: 3.411